Ironwood Investment Management LLC Cytokinetics Inc Transaction History

Ironwood Investment Management LLC

  • $191 Million
  • Q4 2024

A detailed history of Ironwood Investment Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Ironwood Investment Management LLC holds 59,085 shares of CYTK stock, worth $2.53 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
59,085
Previous 59,545 0.77%
Holding current value
$2.53 Million
Previous $3.14 Million 11.58%
% of portfolio
1.46%
Previous 1.59%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$46.36 - $58.62 $21,325 - $26,965
-460 Reduced 0.77%
59,085 $2.78 Million
Q3 2024

Nov 14, 2024
SELL
$51.22 - $60.16 $15,366 - $18,048
-300 Reduced 0.5%
59,545 $3.14 Million
Q2 2024

Aug 16, 2024
BUY
$47.86 - $75.05 $3,398 - $5,328
71 Added 0.12%
59,845 $3.24 Million
Q1 2024

May 15, 2024
SELL
$63.75 - $108.06 $118,256 - $200,451
-1,855 Reduced 3.01%
59,774 $4.19 Million
Q4 2023

Feb 14, 2024
SELL
$26.88 - $83.49 $12,714 - $39,490
-473 Reduced 0.76%
61,629 $5.15 Million
Q3 2023

Nov 16, 2023
SELL
$29.46 - $36.61 $42,982 - $53,413
-1,459 Reduced 2.3%
62,102 $1.83 Million
Q2 2023

Aug 11, 2023
SELL
$32.62 - $40.75 $13,537 - $16,911
-415 Reduced 0.65%
63,561 $2.07 Million
Q1 2023

May 15, 2023
SELL
$33.36 - $45.71 $66,419 - $91,008
-1,991 Reduced 3.02%
63,976 $2.25 Million
Q4 2022

Jan 31, 2023
SELL
$35.77 - $51.11 $67,676 - $96,700
-1,892 Reduced 2.79%
65,967 $3.02 Million
Q3 2022

Nov 14, 2022
SELL
$38.54 - $54.52 $7,823 - $11,067
-203 Reduced 0.3%
67,859 $3.29 Million
Q2 2022

Aug 12, 2022
SELL
$33.93 - $48.92 $30,537 - $44,028
-900 Reduced 1.31%
68,062 $2.67 Million
Q1 2022

May 10, 2022
SELL
$29.74 - $46.0 $2,884 - $4,462
-97 Reduced 0.14%
68,962 $2.54 Million
Q4 2021

Feb 10, 2022
BUY
$34.35 - $46.38 $37,647 - $50,832
1,096 Added 1.61%
69,059 $3.15 Million
Q3 2021

Nov 12, 2021
SELL
$18.54 - $35.74 $5,135 - $9,899
-277 Reduced 0.41%
67,963 $2.43 Million
Q2 2021

Aug 16, 2021
SELL
$19.79 - $26.99 $18,760 - $25,586
-948 Reduced 1.37%
68,240 $1.35 Million
Q1 2021

May 14, 2021
SELL
$18.57 - $25.68 $12,386 - $17,128
-667 Reduced 0.95%
69,188 $1.61 Million
Q4 2020

Feb 12, 2021
SELL
$15.26 - $28.61 $19,364 - $36,306
-1,269 Reduced 1.78%
69,855 $1.45 Million
Q3 2020

Nov 13, 2020
SELL
$20.58 - $28.96 $1,749 - $2,461
-85 Reduced 0.12%
71,124 $1.54 Million
Q2 2020

Aug 17, 2020
SELL
$11.15 - $24.64 $3,802 - $8,402
-341 Reduced 0.48%
71,209 $1.68 Million
Q1 2020

May 14, 2020
BUY
$8.75 - $16.3 $151,672 - $282,544
17,334 Added 31.97%
71,550 $844,000
Q4 2019

Feb 14, 2020
SELL
$7.95 - $11.84 $17,696 - $26,355
-2,226 Reduced 3.94%
54,216 $575,000
Q3 2019

Nov 13, 2019
SELL
$10.82 - $14.25 $1,698 - $2,237
-157 Reduced 0.28%
56,442 $642,000
Q2 2019

Aug 14, 2019
SELL
$7.95 - $11.25 $85,486 - $120,971
-10,753 Reduced 15.97%
56,599 $637,000
Q1 2019

May 08, 2019
SELL
$5.95 - $10.19 $139,414 - $238,761
-23,431 Reduced 25.81%
67,352 $545,000
Q4 2018

Feb 12, 2019
SELL
$5.91 - $9.29 $60,920 - $95,761
-10,308 Reduced 10.2%
90,783 $574,000
Q3 2018

Nov 13, 2018
SELL
$6.4 - $9.85 $19,232 - $29,599
-3,005 Reduced 2.89%
101,091 $996,000
Q2 2018

Aug 08, 2018
SELL
$6.9 - $9.9 $8,473 - $12,157
-1,228 Reduced 1.17%
104,096 $864,000
Q1 2018

May 01, 2018
SELL
$7.2 - $10.05 $13,068 - $18,240
-1,815 Reduced 1.69%
105,324 $758,000
Q4 2017

Feb 06, 2018
SELL
$7.25 - $15.65 $24,454 - $52,787
-3,373 Reduced 3.05%
107,139 $873,000
Q3 2017

Nov 01, 2017
BUY
$12.0 - $15.0 $1.33 Million - $1.66 Million
110,512
110,512 $1.6 Million

Others Institutions Holding CYTK

# of Institutions
397
Shares Held
122M
Call Options Held
3.46M
Put Options Held
1.86M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.04B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Ironwood Investment Management LLC Portfolio

Follow Ironwood Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email